当前位置:首页 - 行情中心 - 皓元医药(688131) - 财务分析 - 现金流量表

皓元医药

(688131)

  

流通市值:158.14亿  总市值:158.14亿
流通股本:2.12亿   总股本:2.12亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金766,432,277.892,931,609,957.751,995,462,290.691,286,991,589.82
  收到的税费返还21,537,732.4955,684,412.8247,636,291.1210,550,084.59
  收到其他与经营活动有关的现金14,396,505.666,746,383.3553,081,290.4844,555,940.85
  经营活动现金流入小计802,366,515.983,054,040,753.922,096,179,872.291,342,097,615.26
  购买商品、接受劳务支付的现金386,443,763.691,358,965,071.12960,999,728.75657,540,666.17
  支付给职工以及为职工支付的现金247,614,825.91929,006,714.17686,018,543.35458,347,479.04
  支付的各项税费53,917,909.03221,394,364.28176,617,051.42123,794,738.79
  支付其他与经营活动有关的现金77,818,719.79226,925,574.73177,965,154.83112,845,620.77
  经营活动现金流出小计765,795,218.422,736,291,724.32,001,600,478.351,352,528,504.77
  经营活动产生的现金流量净额36,571,297.56317,749,029.6294,579,393.94-10,430,889.51
二、投资活动产生的现金流量:
  收回投资收到的现金1,544,000,0004,524,000,0003,293,000,0001,999,000,000
  取得投资收益收到的现金1,479,331.7811,989,862.727,635,882.075,431,545.64
  处置固定资产、无形资产和其他长期资产收回的现金净额1,157,917.11,921,258.672,306,477.592,306,477.59
  收到的其他与投资活动有关的现金-16,356.08--
  投资活动现金流入小计1,546,637,248.884,537,927,477.473,302,942,359.662,006,738,023.23
  购建固定资产、无形资产和其他长期资产支付的现金38,094,205.48221,785,175.99175,041,970.9597,778,461.61
  投资支付的现金1,248,500,0004,462,000,0002,904,500,0001,638,500,000
  取得子公司及其他营业单位支付的现金7,200,00056,185,133.93--
  投资活动现金流出小计1,293,794,205.484,739,970,309.923,079,541,970.951,736,278,461.61
  投资活动产生的现金流量净额252,843,043.4-202,042,832.45223,400,388.71270,459,561.62
三、筹资活动产生的现金流量:
  吸收投资收到的现金13,675,350.0457,531,626.857,457,667.625,553,658
  其中:子公司吸收少数股东投资收到的现金-20,000,000--
  取得借款收到的现金346,968,221.44897,532,199.32643,547,451.5467,730,500.35
  收到其他与筹资活动有关的现金--16,356.08-
  筹资活动现金流入小计360,643,571.48955,063,826.12701,021,475.18493,284,158.35
  偿还债务支付的现金231,801,105.35631,614,161.21407,312,860.5235,907,509.17
  分配股利、利润或偿付利息支付的现金7,360,268.7278,024,134.5452,999,935.8145,771,939.86
  支付其他与筹资活动有关的现金15,905,378.3568,423,458.1236,972,541.6424,726,039.19
  筹资活动现金流出小计255,066,752.42778,061,753.87497,285,337.95306,405,488.22
  筹资活动产生的现金流量净额105,576,819.06177,002,072.25203,736,137.23186,878,670.13
四、汇率变动对现金及现金等价物的影响-17,323,622.87-1,083,949.138,282,087.8514,329,706.16
五、现金及现金等价物净增加额377,667,537.15291,624,320.29529,998,007.73461,237,048.4
  加:期初现金及现金等价物余额1,164,719,993.02873,095,672.73873,095,672.73873,095,672.73
  期末现金及现金等价物余额1,542,387,530.171,164,719,993.021,403,093,680.461,334,332,721.13
补充资料:
  净利润-231,645,431.33-148,696,287.31
  资产减值准备-134,087,756.31-60,966,824.59
  固定资产和投资性房地产折旧-109,405,023.63-52,860,352.82
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-109,405,023.63-52,860,352.82
  无形资产摊销-10,507,285.73-4,686,024.19
  长期待摊费用摊销-36,425,102.07-19,851,714.33
  处置固定资产、无形资产和其他长期资产的损失--793,500.41--616,971.72
  固定资产报废损失-19,237,868.94--
  公允价值变动损失--73,589.04--212,602.74
  财务费用-68,987,706.33-18,087,016.02
  投资损失-15,966,771.96--1,247,313.04
  递延所得税--49,803,236.17--22,617,129.06
  其中:递延所得税资产减少--56,500,313.67--22,617,129.06
    递延所得税负债增加-6,697,077.5--
  存货的减少--327,491,978.62--215,153,545.07
  经营性应收项目的减少--149,351,771.85--87,436,239.4
  经营性应付项目的增加-124,143,103.2--30,183,738.18
  其他-24,196,548.27-20,212,972.46
  现金的期末余额-1,164,719,993.02-1,334,332,721.13
  减:现金的期初余额-873,095,672.73-873,095,672.73
  现金及现金等价物的净增加额-291,624,320.29-461,237,048.4
公告日期2026-04-302026-04-232025-10-312025-08-29
审计意见(境内)标准无保留意见
TOP↑